总时间（秒）：14.26
问答时间（秒）：14.10

```json
[
  {
    "variant_string_id": "SNORD11A G1138A",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes a study on SNORD11A mutations and their impact on ribosome biogenesis, leading to dysregulation of RNA processing and ultimately contributing to spinal muscular atrophy (SMA) pathogenesis. The mutations affect the processing of a pre-ribosomal RNA transcript.",
        "judgment": "Yes",
        "reasoning": "The paper directly links SNORD11A mutations to the molecular mechanism of SMA, specifically ribosome biogenesis and RNA processing.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper employs an enzyme activity assay measuring the cleavage of the pre-ribosomal RNA transcript. This assay directly probes the functional consequence of the mutations.",
        "judgment": "Yes",
        "reasoning": "Ribosomal RNA processing is a well-established mechanism in disease pathogenesis; the cleavage assay models the disease mechanism directly.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Sub-step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The assay includes comparisons to wild-type SNORD11A and other known mutant alleles. Experiments were performed in triplicate to ensure reproducibility.",
        "judgment": "Yes",
        "reasoning": "The description explicitly states the use of wild-type and mutant controls (Normal/Abnormal) and confirms multiple replicates.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "The paper tested the G1138A mutant along with other known pathogenic variants of SNORD11A, serving as positive controls.",
        "judgment": "Yes",
        "reasoning": "The variant was compared to known pathogenic mutations within the SNORD11A gene. These constitute a key set of positive controls.",
        "next_step_or_outcome": "Proceed to Step 4"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The enzyme activity assay, which tests the cleavage of the pre-ribosomal RNA transcript, shows reduced activity for the G1138A variant compared to wild-type and other pathogenic alleles. The presence of positive control variants and the use of replicates strengthens this finding."
  }
]
```